257
Views
20
CrossRef citations to date
0
Altmetric

References

  • Blümel JE, Chedraui P, Baron G, et al. Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Menopausal symptoms appear before the menopause and persist 5 years beyond: a detailed analysis of a multinational study. Climacteric 2012;15:542–51
  • Nisar N, Sohoo NA. Frequency of menopausal symptoms and their impact on the quality of life of women: a hospital based survey. J Pak Med Assoc 2009;59:752–6
  • Welton AJ, Vickers MR, Kim J, et al. WISDOM team. Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ 2008;337:a1190
  • Parish SJ, Nappi RE, Krychman ML, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health 2013;5:437–47
  • Gambacciani M, Rosano G, Cappagli B, Pepe A, Vitale C, Genazzani AR. Clinical and metabolic effects of drospirenone-estradiol in menopausal women: a prospective study. Climacteric 2011;14:18–24
  • Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA 2001;285:2891–7
  • Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999–2010. Obstet Gynecol 2012;120:595–603
  • Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled study. JAMA 2002;288:321–33
  • Nassar AH, Abd Essamad HM, Awwad JT, Khoury NG, Usta IM. Gynecologists’ attitudes towards hormone therapy in the post “Women’s Health Initiative” study era. Maturitas 2005;52:18–25
  • Langer RD, Manson JE, Allison MA. Have we come full circle – or moved forward? The Women’s Health Initiative 10 years on. Climacteric 2012;15:206–12
  • Blümel JE, Castelo-Branco C, Chedraui PA, et al. Patients and clinicians attitudes after the Women’s Health Initiative study. Menopause 2004;11:57–61
  • Hodis HN, Collins P, Mack WJ, Schierbeck LL. The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective. Climacteric 2012;15:217–28
  • Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat 2008;107:103–11
  • Brett KM, Chong Y. Hormone replacement therapy: knowledge and use in the United States. Hyattsville, Maryland: National Center for Health Statistics, 2001
  • World Medical Association. Declaration of Helsinki. JAMA 1997;277:925–6
  • CEPAL-ECLAC. Statistical yearbook for Latin America and the Caribbean. Santiago, Chile: United Nations, 2012
  • Blümel JE, Chedraui P, Baron G, et al. Collaborative Group for Research of the Climacteric in Latin America (REDLINC). A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause 2011;18:778–85
  • Heinemman K, Ruebig A, Potthof P. The menopause rating scale (MRS): A methodological review. Qual Life Res 2004;2:45
  • http://www.menopause-rating-scale.info/documents/Ref_Values_CountrGr.pdf. Accessed 17/09/2013
  • http://www.menopause-rating-scale.info/languages.htm. Accessed 17/09/2013
  • Aedo S, Porcile A, Irribarra C. Calidad de vida relacionada con el climaterio en una poblacion Chilena de mujeres saludables. Rev Chil Obstet Ginecol 2006;71:402–9
  • Chedraui P, Aguirre W, Hidalgo L, Fayad L. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas 2007;57:271–8
  • Castelo-Branco C, Blümel JE, Chedraui P, et al. Age at menopause in Latin America. Menopause 2006;13:706–12
  • Sirin SR. Socioeconomic status and academic achievement: a meta analytic review of research. Rev Educ Res 2005;75: 417–53
  • Blümel JE, Castelo-Branco C, Riquelme R, et al. Use of hormone replacement therapy among Chilean women: a comparison between socioeconomic levels. Menopause 2002;9:377–80
  • Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001;52:345–56
  • Smith-DiJulio K, Percival DB, Woods NF, Tao EY, Mitchell ES. Hot flash severity in hormone therapy users/nonusers across the menopausal transition. Maturitas 2007;58:191–200
  • Santos-Sá D, Pinto-Neto AM, Conde DM, Pedro AO, Oliveira SC, Costa-Paiva L. Factors associated with the intensity of hot flashes in climacteric women. Rev Assoc Med Bras 2006;52:413–18
  • Lee MS, Kim JH, Park MS, et al. Factors influencing the severity of menopause symptoms in Korean post-menopausal women. J Korean Med Sci 2010;25:758–65
  • Yoshihara R, Utsunomiya K, Gojo A, et al. Association of polymorphism of estrogen receptor-alpha gene with circulating levels of adiponectin in postmenopausal women with type II diabetes. J Atheroscler Thromb 2009;16:250–5
  • Monterrosa-Castro A, Blümel JE, Portela-Buelvas K, et al. Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Type II diabetes mellitus and menopause: a multinational study. Climacteric 2013;16:663–72
  • Buhling KJ, Daniels B, Studnitz FS, Eulenburg C, Mueck AO. Attitude of German women towards hormone therapy: results of a lay survey. Gynecol Endocrinol 2013;29:460–4
  • Buhling KJ, von Studnitz FS, Jantke A, Eulenburg C, Mueck AO. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women’s Health Initiative study: results of a survey. Menopause 2012;19:1088–91
  • Carroll N. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms. J Womens Health (Larchmt) 2010;19:47–55
  • NAMS. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013;20:888–902
  • Jalava-Broman J, Mäkinen J, Ojanlatva A, Jokinen K, Sillanmäki L, Rautava P. Change in the frequency of HRT use from 2000 to 2005 and reasons to discontinue: follow-up of a normal cohort in Finland. Acta Obstet Gynecol Scand 2011;90:351–7
  • Corrado F, D’Anna R, Caputo F, Cannata ML, Zoccali MG, Cancellieri F. Compliance with hormone replacement therapy in postmenopausal Sicilian women. Eur J Obstet Gynecol Reprod Biol 2005;118:225–8
  • Sahin NH, Bal MD, Boğa NM, Gökdemirel S, Taşpınar A. Women’s perception of the menopause and hormone treatment: barriers against hormone therapy. Climacteric 2011;14:152–6
  • Alwi SA, Rubiah ZS, Lee PY, Mallika PS, Haizal MN. Experience of hormone replacement therapy among women of Sarawak, Malaysia. Climacteric 2010;13:553–60
  • Low Dog T. Menopause: a review of botanical dietary supplements. Am J Med 2005;118(Suppl 12B):98–108

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.